Related Experiment Video
Updated: May 9, 2026
05:42
Detection and Removal of Tooth-Colored Composite Resin Using the Fluorescence-Aided Identification Technique
Published on: July 27, 2022
Managing the phase-down of amalgam: Part I. Educational and training issues
1Reader/Honorary Consultant in Restorative Dentistry, School of Dentistry, Cardiff University, Cardiff. lynchcd@cardiff.ac.uk
British Dental Journal
|August 10, 2013
Summary
Dental amalgam use will phase down due to the Minamata Convention. Dental professionals need mindset shifts to prioritize patient safety with alternatives like posterior composites, despite some reluctance.
Area of Science:
- Dental materials science and restorative dentistry.
Background:
- The Minamata Convention mandates a phase-down of dental amalgam use.
- Posterior composites are established alternatives, yet practitioner reluctance persists.
- Patient safety necessitates a transition away from amalgam.
Purpose of the Study:
- To examine the current and future use of posterior composites.
- To identify strategies for successful dental amalgam phase-down.
- To explore the role of education in promoting composite adoption.
Main Methods:
- Review of existing evidence on posterior composite efficacy and placement.
- Analysis of factors influencing practitioner adoption of dental materials.
- Consideration of educational strategies for dental professionals.
Main Results:
- Posterior composites offer a viable and often preferable alternative to amalgam.
- Despite advancements and evidence, many dentists hesitate to use composites.
- Educational initiatives are crucial for overcoming reluctance.
Conclusions:
- A successful phase-down of dental amalgam requires significant professional adaptation.
- Enhanced dental school teaching and continuing professional development are key.
- Transitioning to posterior composites ensures continued high standards of patient care.
Related Concept Videos
01:19Masking and Demasking Agents
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...